Amgen (AMGN) PT Lowered to $216 at RBC Capital
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $351.40 +1.27%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 52
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 52
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $216.00 (from $217.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- Bank of Queensland Ltd. (BOQ:AU) (BKQNY) PT Lowered to AUD6.80 at UBS
- Daiwa Securities Group Inc. (8601:JP) (DSEEY) PT Raised to JPY1,720 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
